How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?

被引：0
|
作者：
Michael Drummond
Oriana Ciani
Giulia Fornaro
Claudio Jommi
Eva Susanne Dietrich
Jaime Espin
Jean Mossman
Gerard de Pouvourville
机构：
[1] University of York,Centre for Health Economics
[2] CERGAS,Patient Representative and Visiting Senior Research Associate in the Medical Technology Research Group
[3] SDA Bocconi School of Management,undefined
[4] University of Bonn Pharmaceutical Institute,undefined
[5] Andalusian School of Public Health,undefined
[6] LSE Health,undefined
[7] London School of Economics,undefined
[8] ESSEC,undefined
来源：
BMC Health Services Research | / 23卷
关键词：
Cost-effectiveness analysis; Advanced therapy medicinal products; Health technology assessment; Managed entry agreements; Reimbursement;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?
    Drummond, Michael
    Ciani, Oriana
    Fornaro, Giulia
    Jommi, Claudio
    Dietrich, Eva Susanne
    Espin, Jaime
    Mossman, Jean
    de Pouvourville, Gerard
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [2] ARE HEALTH TECHNOLOGY ASSESSMENT (HTA) BODIES RESPONDING TO THE ASSESSMENT CHALLENGES POSED BY CELL AND GENE THERAPIES?
    Fornaro, G.
    Drummond, M.
    Ciani, O.
    Jommi, C.
    VALUE IN HEALTH, 2022, 25 (07) : S297 - S297
  • [3] KEY FEATURES AND CHALLENGES OF CELL AND GENE THERAPIES HIGHLIGHTED IN HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSIONS
    Tran, J.
    Vu, B. K.
    Campden, R.
    Zhou, M.
    Musat, M.
    Thakur, D.
    VALUE IN HEALTH, 2023, 26 (06) : S260 - S261
  • [4] Changes and challenges in health technology assessment
    Cameron, Alun
    Ma, Ning
    Babidge, Wendy
    Maddern, Guy
    ANZ JOURNAL OF SURGERY, 2024, 94 (06) : 986 - 988
  • [5] IMPACT OF COVID ON HEALTH TECHNOLOGY ASSESSMENT BODIES
    Macaulay, R.
    VALUE IN HEALTH, 2021, 24 : S187 - S187
  • [6] Future of health technology assessment studies in gene and cell therapies
    Yarpuzlu, Aysegul Akbay
    Atak, Nazli
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2007, 6 (14): : 1603 - 1607
  • [7] Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies
    Aris Angelis
    Huseyin Naci
    Allan Hackshaw
    PharmacoEconomics, 2020, 38 : 1297 - 1308
  • [8] Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies
    Angelis, Aris
    Naci, Huseyin
    Hackshaw, Allan
    PHARMACOECONOMICS, 2020, 38 (12) : 1297 - 1308
  • [9] UNDERSTANDING HOW HEALTH TECHNOLOGY ASSESSMENT BODIES SELECT MEDICAL TECHNOLOGY FOR REVIEW: RESULTS OF AN ONLINE SURVEY
    Gildea, L.
    Mordin, M.
    Long, J.
    D'Souza, V
    Kinderas, M.
    Warttig, S.
    Hartley, L.
    Ling, C.
    VALUE IN HEALTH, 2023, 26 (12) : S432 - S432
  • [10] CHALLENGES IN HEALTH TECHNOLOGY ASSESSMENT OF COMPLEX HEALTH TECHNOLOGIES
    Hogervorst, M.
    Vreman, R.
    Mantel-Teeuwisse, A. K.
    Goettsch, W.
    VALUE IN HEALTH, 2020, 23 : S668 - S669
12345